Highbridge Capital Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Hold |
0
| – | – | – | 1300 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 1242 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 1338 |
|
|
2016
Q4 | – | Sell |
-63,548
| Closed | -$402K | – | 1418 |
|
|
2016
Q3 | $402K | Buy |
+63,548
| New | +$402K | 0.01% | 739 |
|
|
2016
Q1 | – | Sell |
-78,134
| Closed | -$479K | – | 1246 |
|
|
2015
Q4 | $479K | Buy |
78,134
+29,705
| +61% | +$182K | 0.01% | 563 |
|
|
2015
Q3 | $277K | Buy |
+48,429
| New | +$277K | ﹤0.01% | 747 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 1168 |
|
|
2015
Q1 | – | Sell |
-46,478
| Closed | -$351K | – | 1118 |
|
|
2014
Q4 | $351K | Buy |
+46,478
| New | +$351K | ﹤0.01% | 595 |
|
|
2014
Q2 | – | Sell |
-172,960
| Closed | -$708K | – | 988 |
|
|
2014
Q1 | $708K | Buy |
+172,960
| New | +$708K | 0.01% | 469 |
|
|
2013
Q4 | – | Sell |
-266,719
| Closed | -$1.34M | – | 1042 |
|
|
2013
Q3 | $1.34M | Buy |
266,719
+189,284
| +244% | +$950K | 0.01% | 515 |
|
|
2013
Q2 | $346K | Buy |
+77,435
| New | +$346K | ﹤0.01% | 742 |
|